<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVES: <z:e sem="disease" ids="C0220650" disease_type="Neoplastic Process" abbrv="">Brain metastases</z:e> from <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (crc) are quite rare </plain></SENT>
<SENT sid="1" pm="."><plain>Here, we review the characteristics, presentation, and clinical course of such patients at our institution </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: We reviewed the medical records of patients with <z:e sem="disease" ids="C0220650" disease_type="Neoplastic Process" abbrv="">brain metastases</z:e> from crc treated during 2000-2009 </plain></SENT>
<SENT sid="3" pm="."><plain>Associations between patient, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> characteristics, treatment modality, and survival were assessed using the Kaplan-Meier method </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: We identified 48 patients (25 men, 23 women) who developed <z:e sem="disease" ids="C0220650" disease_type="Neoplastic Process" abbrv="">brain metastases</z:e> from crc </plain></SENT>
<SENT sid="5" pm="."><plain>The median age at diagnosis of the <z:e sem="disease" ids="C0220650" disease_type="Neoplastic Process" abbrv="">brain metastases</z:e> was 63 years (range: 37-84 years) </plain></SENT>
<SENT sid="6" pm="."><plain>In 23 of the patients (48%), the <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumour</z:e> occurred in the rectum </plain></SENT>
<SENT sid="7" pm="."><plain>At diagnosis of <z:e sem="disease" ids="C0220650" disease_type="Neoplastic Process" abbrv="">brain metastases</z:e>, 43 patients (90%) also had other systemic <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> (mainly pulmonary and hepatic) </plain></SENT>
<SENT sid="8" pm="."><plain>The median interval between diagnosis of the <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumour</z:e> and of the <z:e sem="disease" ids="C0220650" disease_type="Neoplastic Process" abbrv="">brain metastases</z:e> was 24 months </plain></SENT>
<SENT sid="9" pm="."><plain>Median survival after a diagnosis of <z:e sem="disease" ids="C0220650" disease_type="Neoplastic Process" abbrv="">brain metastasis</z:e> from crc was 4 months (range: 1-13 months) </plain></SENT>
<SENT sid="10" pm="."><plain>We observed substantially better survival (13 months, p &lt; 0.001) in patients treated with surgery followed by whole-brain radiotherapy (wbrt) than in those treated with radiotherapy or surgery alone </plain></SENT>
<SENT sid="11" pm="."><plain>Sex, age, location and number of <z:e sem="disease" ids="C0220650" disease_type="Neoplastic Process" abbrv="">brain metastases</z:e>, and timing of diagnosis did not affect survival </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSIONS: <z:e sem="disease" ids="C0220650" disease_type="Neoplastic Process" abbrv="">Brain metastases</z:e> from crc develop late in the course of the disease, given that most patients already have other secondary lesions </plain></SENT>
<SENT sid="13" pm="."><plain>Prognosis in these patients is poor, with those receiving treatment with surgery and wbrt having the best overall survival </plain></SENT>
<SENT sid="14" pm="."><plain>Early detection and treatment of <z:e sem="disease" ids="C0220650" disease_type="Neoplastic Process" abbrv="">brain metastases</z:e> with new systemic therapies may improve outcomes </plain></SENT>
</text></document>